HWHG(SH:600079) Shang Hai Zheng Quan Bao·2025-11-07 21:16Core Viewpoint - The announcement details the pledge of shares by the controlling shareholder of Renfu Pharmaceutical Group Co., Ltd., indicating a significant portion of shares has been pledged, but it does not pose a risk to the company's operations or governance [1][4]. Summary by Sections Share Pledge Situation - As of the announcement date,招商生命科技 (Wuhan) Co., Ltd. holds 130,829,531 shares of Renfu Pharmaceutical, accounting for 8.02% of the total share capital. After this pledge, the total pledged shares amount to 97,933,558, which is 74.86% of its holdings and 6% of the total share capital [2][3]. - The pledge includes 40,433,558 unrestricted shares and 57,500,000 restricted shares, with all necessary procedures completed at the China Securities Depository and Clearing Corporation [3]. Cumulative Pledge Situation - The cumulative pledged shares by招商生科 and its concerted parties total 97,933,558, representing 21.97% of their combined holdings and 6% of the total share capital [2][4]. - There are no upcoming expirations of pledged shares within the next six months to one year, and the controlling shareholder has a good credit status and repayment capability [4]. Impact on Company Operations - The share pledge will not significantly impact the company's operations or governance, nor will it lead to a change in actual control. The pledged shares are not related to performance compensation obligations [4]. - The company will continue to monitor the situation regarding share pledges and associated risks, ensuring compliance with relevant disclosure obligations [4].